Tilray (NASDAQ:TLRY) Shares Up 2.6%

Tilray Inc (NASDAQ:TLRY) was up 2.6% during trading on Monday . The company traded as high as $1.80 and last traded at $1.78. Approximately 4,222,814 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 26,589,881 shares. The stock had previously closed at $1.73.

Analyst Ratings Changes

Several analysts recently commented on TLRY shares. Alliance Global Partners increased their target price on shares of Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a research note on Friday, April 5th. Canaccord Genuity Group cut their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, CIBC decreased their target price on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th.

Tilray Stock Performance

The firm’s 50-day moving average price is $1.82 and its two-hundred day moving average price is $1.93. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.42 billion, a PE ratio of -4.16 and a beta of 2.19.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Simplicity Wealth LLC purchased a new stake in Tilray in the 1st quarter worth about $28,000. RPO LLC acquired a new position in shares of Tilray in the 4th quarter valued at about $28,000. Gainplan LLC purchased a new stake in shares of Tilray in the fourth quarter worth approximately $28,000. Wellington Wealth Strategies LLC. purchased a new stake in shares of Tilray in the fourth quarter worth approximately $29,000. Finally, International Assets Investment Management LLC boosted its holdings in shares of Tilray by 179.0% during the fourth quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock worth $34,000 after purchasing an additional 9,453 shares during the period. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.